New Tanning Drug Could Protect Skin From the Sun

3

Scientists may have figured out a way to let people tan safely – without involving the sun.

In an effort to further develop preventative measures for skin cancers like melanoma, researchers from Dana-Farber and other health care organizations have developed a potential topical cream that stimulates skin cells to produce the dark pigment, melanin. Melanin helps protect skin cells by absorbing harmful ultraviolet (UV) rays; skin cancer is usually caused by overexposure to those UV rays. Scientists have stressed that more research and clinical trials are needed, but say the drug could be a promising pathway for UV protection and reducing skin cancer risk.

“There are pure cosmetic uses – people like to be tan – and there’s potential protection from skin cancer, as well as clear medical use for people that have hyper sun-sensitive disorders,” says Nathanael Gray, PhD, professor of cancer biology at Dana-Farber and a lead researcher on the study.

While the incidence rate of skin cancer has increased in the United States over the past couple of decades, darker skinner individuals maintain a lower risk of developing skin cancer over their lifetime. Researchers wanted to develop a method that could tan fair-skinned individuals without using any ultraviolet (UV) light. This new topical cream carries a small molecule that stimulates the synthesis of eumelanin, the melanin responsible for dark pigments.

A 2006 study was the first to find a topical drug successful in tanning red-haired mice, but researchers had difficulty getting the drug to penetrate the thickness of human skin. More than a decade later, a new generation of drug has been optimized to stimulate the browning of human skin.

Like natural tanning, the pigmentation naturally fades over time, meaning a potential treatment will include consistent application for its effects. The treatment not only promotes the production of melanin, but also the healthy maturation of melanosomes, the cells that process and hold melanin.

So what are the next steps? Gray says a potential new study could test whether a combination of this new drug and sunscreen could protect against skin cancer in fair-skinned people or people who are particularly sun-sensitive. More research also has to be done on side effects of the drug, he says.

“Obviously sunscreen is pretty universally used and accepted, and a study would have to be done to show that darkening your skin plus sunscreen is better than sunscreen alone,” Gray says. “That’s not a given.”

Learn more about the latest in skin cancer research at Dana-Farber and when to see a dermatologist.

Comments Sort By Newest

3 thoughts on “New Tanning Drug Could Protect Skin From the Sun

  1. What are your thoughts in regards to (in layoerson’s) terms these super anti oxidants originally studied in regards to oxidative stress such as Protandim? (Disregarding the recent action taken regarding overstating claims regarding specific diseases. I think in one case they even claimed to have cured melanoma.
    With eyes wide open in regards to knowing they are no cure for anything. In your opinion are they still beneficial to the extreme? (Usually suggested the dose be accompanied by omega 3 and several other supplements.

  2. What are your thoughts in regards to (in layoerson’s) terms these super anti oxidants originally studied in regards to oxidative stress such as Protandim? (Disregarding the recent action taken regarding overstating claims regarding specific diseases. I think in one case they even claimed to have cured melanoma.
    With eyes wide open in regards to knowing they are no cure for anything. In your opinion are they still beneficial to the extreme? (Usually suggested the dose be accompanied by omega 3 and several other supplements.

Leave a Reply

Your email address will not be published. Required fields are marked *

Blue Captcha Image
Refresh

*

Most Read Stories

Sorry. No data so far.

Make An Appointment

For adults: 877-960-1562

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.

Latest Tweets

Dana-Farber @danafarber
9/27: Join Dana-Farber's Dr. Lewis Silverman to hear the latest in pediatric acute lymphoblastic #leukemia research… https://t.co/1FkU2v2smy
Dana-Farber @danafarber
Meet Caron Jacobson, MD: Principal investigator for a CAR T-cell trial for diffuse large B-cell #lymphoma.… https://t.co/UeSeVQEhEY
Dana-Farber @danafarber
Former Dana-Farber cancer patients (now survivors) share their advice for patients new to treatment. Read more:… https://t.co/VDZmU8ZZve

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.